Figure 2 | Scientific Reports

Figure 2

From: Analysis of survival and prognostic factors of clear cell adenocarcinoma of the prostate: a case–control study for a rare cancer entity

Figure 2

The survival rates of CCPC patients compared with those with APC after PSM. (2A) CCPC patients had a higher CSM ratio (41.5% vs. 27.7%, p < 0.05); (2B) CCPC patients had a higher OM ratio (99.2% vs. 90.8%, p < 0.01). CCPC = Clear cell adenocarcinoma of the prostate; APC = acinar carcinoma of the prostate; CSM = cancer-specific mortality; OM = overall mortality; PSM = propensity score matching.

Back to article page